Tango Therapeutics
TNGX
TNGX
137 hedge funds and large institutions have $329M invested in Tango Therapeutics in 2024 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
58% less capital invested
Capital invested by funds: $781M → $329M (-$452M)
71% less call options, than puts
Call options by funds: $4K | Put options by funds: $14K
Holders
137
Holding in Top 10
6
Calls
$4K
Puts
$14K
Top Buyers
| 1 | +$33.2M | |
| 2 | +$12.4M | |
| 3 | +$8.67M | |
| 4 |
BOCH
Blue Owl Capital Holdings
New York
|
+$5.35M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$2.03M |
Top Sellers
| 1 | -$38.5M | |
| 2 | -$29M | |
| 3 | -$17.7M | |
| 4 |
DM
Deerfield Management
New York
|
-$11.9M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$8.34M |